From preclinical through launch, we design and execute clinical development, regulatory, microbiology, biometrics, and medical affairs strategy across the infectious disease, immunology, critical care, rare disease, and diagnostics markets.

​

Trusted by 100+ clients, 100+ clinical trials, 45+ product launches, and 40+ regulatory submissions.

​

Deep, hands-on experience across the life sciences, from Phase 1 through Phase 3 programs in infectious disease, immunology, critical care, and rare disease therapeutics.

​

Schedule a conversation to discuss how we can support you and your program needs.